Biogen Idec (BIIB), Elan (ELN) to Present Positive Data for Tysabri on MS Supporting JCV
Tweet Send to a Friend
Biogen Idec, Inc. (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced results from several studies of TYSABRI (natalizumab) that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
